PROSPECTS AND OPPORTUNITIES
The dengue outbreak fuels consumption and drives sales of acetaminophen
The Uruguayan health ministry anticipates that 2025 will be a record year for dengue; a tropical disease transmitted by mosquitoes. Despite the uncomfortable symptoms of this illness, many types of analgesics are not recommended in cases of dengue infection.
Herbal/traditional products showcase growth, driven by natural options
While generics still account for relatively low value sales, they are expected to gain a larger foothold over the forecast period. While there will be reticence about generic offerings, consumers increasingly appreciate the price/quality combination.
Online sales expand as e-commerce increases in popularity
E-commerce sales have increased since 2020, as consumers become familiar with, and reliant on the convenience of online shopping. With the rise of e-commerce, new opportunities are opened for the promotion and sale of products in this category.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Uruguay with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Uruguay, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Uruguay report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Uruguay?
- Which are the leading brands in Analgesics in Uruguay?
- How are products distributed in Analgesics in Uruguay?
- How has the regulatory and operating environment for Analgesics changed in Uruguay?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Uruguay - Category analysis
KEY DATA FINDINGS
Retail value sales rise as illicit trade from Argentina falls
The ongoing dengue outbreak drives sales of acetaminophen
Innovation remains high, capturing a wider consumer base
The dengue outbreak fuels consumption and drives sales of acetaminophen
Herbal/traditional products showcase growth, driven by natural options
Online sales expand as e-commerce increases in popularity
Consumer Health in Uruguay - Industry Overview
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!